Association of the congenital neuromuscular form of glycogen storage disease type IV with a large deletion and recurrent frameshift mutation
- PMID: 21917543
- DOI: 10.1177/0883073811415107
Association of the congenital neuromuscular form of glycogen storage disease type IV with a large deletion and recurrent frameshift mutation
Abstract
Anderson disease, also known as glycogen storage disease type IV (MIM 232500), is a rare autosomal recessive disorder caused by a deficiency of glycogen branching enzyme. Glycogen storage disease type IV has a broad clinical spectrum ranging from a perinatal lethal form to a nonprogressive later-onset disease in adults. Here, we report 2 unrelated infants who were born small for their gestational age and who had profound hypotonia at birth and thus needed mechanical ventilation. Both of these patients shared the same frameshift mutation (c.288delA, pGly97GlufsX46) in the GBE1 gene. In addition, both of these patients were found to have 2 different large deletions in the GBE1 gene; exon 7 and exons 2 to 7, respectively, on the other alleles. This case report also highlights the need for a more comprehensive search for large deletion mutations associated with glycogen storage disease type IV, especially if routine GBE1 gene sequencing results are equivocal.
Similar articles
-
Diffuse reticuloendothelial system involvement in type IV glycogen storage disease with a novel GBE1 mutation: a case report and review.Hum Pathol. 2012 Jun;43(6):943-51. doi: 10.1016/j.humpath.2011.10.001. Epub 2012 Feb 2. Hum Pathol. 2012. PMID: 22305237 Review.
-
A case of congenital glycogen storage disease type IV with a novel GBE1 mutation.J Child Neurol. 2008 Mar;23(3):349-52. doi: 10.1177/0883073807309248. Epub 2008 Jan 29. J Child Neurol. 2008. PMID: 18230843
-
Null mutations and lethal congenital form of glycogen storage disease type IV.Biochem Biophys Res Commun. 2007 Sep 21;361(2):445-50. doi: 10.1016/j.bbrc.2007.07.074. Epub 2007 Jul 24. Biochem Biophys Res Commun. 2007. PMID: 17662246
-
Branching enzyme deficiency/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: muscle biopsy and autopsy findings, biochemical and molecular genetic studies.Neuromuscul Disord. 2010 Dec;20(12):783-90. doi: 10.1016/j.nmd.2010.07.275. Epub 2010 Sep 15. Neuromuscul Disord. 2010. PMID: 20833045
-
Neonatal presentation of lethal neuromuscular glycogen storage disease type IV.J Perinatol. 2012 Oct;32(10):810-3. doi: 10.1038/jp.2011.178. J Perinatol. 2012. PMID: 23014386 Review.
Cited by
-
Case report: Familial glycogen storage disease type IV caused by novel compound heterozygous mutations in a glycogen branching enzyme 1 gene.Front Genet. 2022 Nov 8;13:1033944. doi: 10.3389/fgene.2022.1033944. eCollection 2022. Front Genet. 2022. PMID: 36425069 Free PMC article.
-
Two cases of a non-progressive hepatic form of glycogen storage disease type IV with atypical liver pathology.Mol Genet Metab Rep. 2020 May 18;24:100601. doi: 10.1016/j.ymgmr.2020.100601. eCollection 2020 Sep. Mol Genet Metab Rep. 2020. PMID: 32455116 Free PMC article.
-
Analysis of GBE1 mutations via protein expression studies in glycogen storage disease type IV: A report on a non-progressive form with a literature review.Mol Genet Metab Rep. 2018 Sep 13;17:31-37. doi: 10.1016/j.ymgmr.2018.09.001. eCollection 2018 Dec. Mol Genet Metab Rep. 2018. PMID: 30228975 Free PMC article.
-
Update Review about Metabolic Myopathies.Life (Basel). 2020 Apr 17;10(4):43. doi: 10.3390/life10040043. Life (Basel). 2020. PMID: 32316520 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
